Anecortave Acetate Risk Reduction Trial (AART)

NCT00332657 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

36

Enrollment

INDUSTRY

Sponsor class

Stopped Management Decision

Conditions

AMD

Interventions

DRUG: Anecortave Acetate Sterile Suspension, 30 mg/mL
DRUG: Anecortave Acetate Sterile Suspension, 60 mg/mL
OTHER: Anecortave Acetate Vehicle

Sponsor

Alcon Research